Buscas alternativas:
decrease processes » disease processes (Expandir a busca), defense processes (Expandir a busca), decay processes (Expandir a busca)
decrease decrease » decrease release (Expandir a busca), decreases disease (Expandir a busca), disease decreases (Expandir a busca)
decrease after » disease after (Expandir a busca)
nmda decrease » and decrease (Expandir a busca), not decrease (Expandir a busca), may decrease (Expandir a busca)
decrease toc » decrease of (Expandir a busca), decrease the (Expandir a busca), decreased to (Expandir a busca)
toc decrease » to decrease (Expandir a busca), the decrease (Expandir a busca), not decrease (Expandir a busca)
decrease processes » disease processes (Expandir a busca), defense processes (Expandir a busca), decay processes (Expandir a busca)
decrease decrease » decrease release (Expandir a busca), decreases disease (Expandir a busca), disease decreases (Expandir a busca)
decrease after » disease after (Expandir a busca)
nmda decrease » and decrease (Expandir a busca), not decrease (Expandir a busca), may decrease (Expandir a busca)
decrease toc » decrease of (Expandir a busca), decrease the (Expandir a busca), decreased to (Expandir a busca)
toc decrease » to decrease (Expandir a busca), the decrease (Expandir a busca), not decrease (Expandir a busca)
1
“... after piperine (2.5, 5, 10 and 20 mg/kg, i.p.) which significantly increased latencies to 1st convulsion...”
Acessar documento (1)
Acessar documento (2)
Acessar documento (1)
Acessar documento (2)
Artigo
2
“... after piperine (2.5, 5, 10 and 20 mg/kg, i.p.) which significantly increased latencies to 1st convulsion...”
Acessar documento
Acessar documento
Artigo
3
4
5
6
7
8
9
“...Entendendo a importÃncia do papel dos receptores NMDA e do magnÃsio como modulador desse receptor...”
Acessar documento
Acessar documento
Dissertação
10
“... por antagonistas dos receptores NMDA mimetiza os sintomas da esquizofrenia. Muitos modelos animais têm mostrado...”
Acessar documento
Acessar documento
Tese
11
“... nmol), a CRF type 1 receptor antagonist (CRF1), or AP-7 (0, 0.05, 0.10 or 0.20 nmol), a NMDA receptor...”
Acessar documento
Acessar documento
Dissertação
12
13
14
15
16
17
18
19
20
“... a decrease on PKA phosphorylation and reverted it with the administration of d-ciclosserin, a NMDA coagonist...”
Acessar documento (1)
Acessar documento (2)
Acessar documento (1)
Acessar documento (2)
Tese